Author:
Wu Mary Y,Carr Edward J,Harvey Ruth,Mears Harriet V,Kjaer Svend,Townsley Hermaleigh,Hobbs Agnieszka,Ragno Martina,Herman Lou S,Adams Lorin,Gamblin Steve,Howell Michael,Beale Rupert,Brown Michael,Williams Bryan,Gandhi Sonia,Swanton Charles,Wall Emma C,Bauer David L V
Funder
Wellcome Trust
The Francis Crick Institute
Medical Research Council
AstraZeneca
Cancer Research UK
Reference17 articles.
1. Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform;Zheng;bioRxiv,2022
2. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination;Wall;Lancet,2021
3. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC;Wall;Lancet,2021
4. Three-dose vaccination elicits neutralising antibodies against omicron;Wu;Lancet,2022
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献